Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Doxorubicin (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms MIRACLE-I
- 03 Oct 2016 Biomarkers information updated
- 04 Mar 2013 New trial record